Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Our first program is focused on a disease-modifying therapeutic for neurodegenerative diseases.
Company Details
- Employees
- 14
- Founded
- 2017
- Address
- 700 Main Street North, Cambridge,ma 02139,united States
- Phone
- (617) 308-4405
- Industry
- Biotechnology
- Website
- http://www.eikonizo.com
- HQ
- Cambridge, MA
Eikonizo Therapeutics Questions
Eikonizo Therapeutics's helpline number is (617) 308-4405
Eikonizo Therapeutics's website is http://www.eikonizo.com
Eikonizo Therapeutics's LinkedIn profile is https://www.linkedin.com/company/eikonizo-therapeutics
Eikonizo Therapeutics has
14 employees.
View email and phone details for 14
employees at Eikonizo Therapeutics.
Eikonizo Therapeutics's industry is
Biotechnology
Eikonizo Therapeutics's top competitors are
Gilgamesh Pharmaceuticals,
Leal Therapeutics,
Brenig Therapeutics,
Neumora,
Noema Pharma,
Delix Therapeutics,
Neurosense Therapeutics,
Kariya Pharmaceuticals,
Quralis,
Sensorium Therapeutics.
Eikonizo Therapeutics's categories are Biotechnology
Eikonizo Therapeutics's founding year is 2017
